These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Pathogenetic therapy in the combined treatment of patients with chronic pyelonephritis]. Ukhal' MI Vrach Delo; 1983 Jan; (1):84-7. PubMed ID: 6868509 [No Abstract] [Full Text] [Related]
5. [State of humoral and cellular immunity in chronic pyelonephritis]. Dziak VN; Liul'ko AV; Kropinov PI Vrach Delo; 1981 Feb; (2):3-7. PubMed ID: 7222604 [No Abstract] [Full Text] [Related]
6. [The bioregulatory therapy of patients with chronic pyelonephritis]. al-Shukri SKh; Gorbachev AG; Kuz'min IV Urol Nefrol (Mosk); 1997; (4):6-8. PubMed ID: 9381626 [TBL] [Abstract][Full Text] [Related]
7. [5-nitro-8-oxyquinoline in the treatment of chronic pyelonephritis]. Leńko J; Markiewicz K; Trznadel K Pol Tyg Lek; 1974 Jun; 29(24):1045-7. PubMed ID: 4602504 [No Abstract] [Full Text] [Related]
8. [Clinical evaluation of nalidixic acid (nevigramon) in the treatment of chronic pyelonephritis]. Chodorowski Z; Hebanowski M Pol Tyg Lek; 1973 Aug; 28(33):1282-4. PubMed ID: 4742302 [No Abstract] [Full Text] [Related]
9. [Use of stimulating doses of antilymphocytic gamma globulin in the complex treatment of chronic osteomyelitis of the lower limbs]. Iusubov IuA Vrach Delo; 1975 Apr; (4):98-100. PubMed ID: 56088 [No Abstract] [Full Text] [Related]
10. [Clinico-immunological evaluation of the effectiveness of delagil and homologous gamma globulin (normal immunoglobulin) in viral hepatitis]. Startseva GG Vrach Delo; 1978 Oct; (10):138-42. PubMed ID: 82297 [No Abstract] [Full Text] [Related]
11. [Essential phospholipids in the treatment of chronic pyelonephritis]. Ovchinnikov AA; Tsvettsikh VE; Berdichevskiĭ BA; Lykov VN; Suktanbaev VR; Murychev AV Urol Nefrol (Mosk); 1996; (4):7-9. PubMed ID: 8928353 [TBL] [Abstract][Full Text] [Related]
13. [The dynamics of the nonspecific immunity indices during the lymphotropic therapy of children with acute pyelonephritis]. Illek IaIu; Zuĭ OG; Ganieva MSh Urol Nefrol (Mosk); 1993; (5):15-7. PubMed ID: 8310576 [TBL] [Abstract][Full Text] [Related]
14. [Clinical laboratory aspects of the use of morpholevocycline in calculous pyelonephritis]. Kurashkin AG Sov Med; 1978 Oct; (10):18-21. PubMed ID: 152468 [No Abstract] [Full Text] [Related]
15. [Evaluation of the natural immunity of patients with chronic pyelonephritis (skin test with pyrogenal)]. Kobelev AA; Lifanov GIa; Kosareva PI Sov Med; 1982; (3):100-1. PubMed ID: 7101021 [No Abstract] [Full Text] [Related]
16. [The immune status of patients with primary and secondary chronic pyelonephritis]. al-Shukri SKh; Gorbachev AG; Smironov VS; Kuz'min IV Urol Nefrol (Mosk); 1996; (3):17-20. PubMed ID: 8928323 [TBL] [Abstract][Full Text] [Related]
17. [A new antibiotic in the therapy of chronic pyelonephritis]. Porpáczy P Wien Med Wochenschr; 1970 Oct; 120(42):743-5. PubMed ID: 4100627 [No Abstract] [Full Text] [Related]
18. [Use of decaris in chronic pyelonephritis]. Glezer GA; Rachkov SM; Briker VA; Charyev M Sov Med; 1981; (2):85-7. PubMed ID: 7244815 [No Abstract] [Full Text] [Related]
19. [Treatment of nonspecific pyelonephritis in renal tuberculosis]. Minakov NK Sov Med; 1986; (10):109-11. PubMed ID: 3810259 [No Abstract] [Full Text] [Related]